The Coalition to Transform Advanced Care (C-TAC), a non-profit organization with a vision of improving advanced illness care for all Americans, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School co-hosted the inaugural event for their new collaboration: The Project on Advanced Care and Health Policy.
Charles Ogletree ’78, the Jesse Climenko Professor of Law and director of the Charles Hamilton Houston Institute for Race & Justice at Harvard Law School, recently announced that he has been diagnosed with Alzheimer’s disease. He said he will work to raise awareness of the disease and its disproportionate effect on African Americans.
Harvard Law School Professor I. Glenn Cohen, faculty director of the School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday’s ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.
When a severe speech impediment left him struggling to be understood, food became a way for Tommy Tobin ’16 to connect with others. In high school he volunteered at a food bank and with the Boys & Girls Clubs of America, and watched his actions speak volumes. “Speaking through service became a theme for me.”
“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”